Literature DB >> 1181073

Sorbitol and other polyols in lens, adipose tissue and urine in diabetes mellitus.

D J Heaf, D J Galton.   

Abstract

Sugars and polyols (glucose, fructose, sorbitol, inositol and pentitols) have been measured in urine, adipose tissue and lens in groups of diabetic and non-diabetic patients. The daily excretions of glucose, sorbitol and inositol were raised in the diabetics. There was a linear relation between 24 hour urinary excretion of glucose and hexitols (r = +0.87, p less than 0.001). In lens of diabetics there was an increase in glucose concentration, but not of fructose, sorbitol or inositol. Compounds readily detected in adipose tissue were inositol and glucose; in addition an unidentified carbohydrate was detected in adipose tissue that related to the concentration of tissue glucose. These results are discussed in relation to the possibility that tissue accumulation of polyols could be responsible for the secondary complications of diabetes such as cataracts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1181073     DOI: 10.1016/0009-8981(75)90376-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  The link between hyperglycaemia and diabetic nephropathy.

Authors:  R G Larkins; M E Dunlop
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

2.  Age-related accumulation of Maillard reaction products in human articular cartilage collagen.

Authors:  N Verzijl; J DeGroot; E Oldehinkel; R A Bank; S R Thorpe; J W Baynes; M T Bayliss; J W Bijlsma; F P Lafeber; J M Tekoppele
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

3.  Activated and unactivated forms of human erythrocyte aldose reductase.

Authors:  S K Srivastava; G A Hair; B Das
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Scopoletin inhibits rat aldose reductase activity and cataractogenesis in galactose-fed rats.

Authors:  Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; So Dam Shin; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-11       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.